Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://sentinelinitiative.org/methods-data-tools/methods/near-real-time-monitoring-critical-drugs-care-patients-covid-19	Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19	Methods, Data, & Tools	04/20/2020	Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19 Methods, Data, & Tools 04/20/2020
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/36th-international-conference-pharmacoepidemiology-and	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management	Publications and Presentations	09/16/2020	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Publications and Presentations 09/16/2020
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table	Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis	Modular Programs	03/11/2021	Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Modular Programs 03/11/2021
https://sentinelinitiative.org/methods-data-tools/methods/extending-machine-learning-methods-development-sentinel-follow-analyses	Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3)	Methods, Data, & Tools	05/17/2021	Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3) Methods, Data, & Tools 05/17/2021
https://sentinelinitiative.org/methods-data-tools/methods/improving-probabilistic-phenotyping-incident-outcomes-through-enhanced	Improving Probabilistic Phenotyping of Incident Outcomes through Enhanced Ascertainment with Natural Language Processing	Methods, Data, & Tools	05/20/2021	Improving Probabilistic Phenotyping of Incident Outcomes through Enhanced Ascertainment with Natural Language Processing Methods, Data, & Tools 05/20/2021
https://sentinelinitiative.org/methods-data-tools/methods/using-unsupervised-learning-harmonize-data-across-data-systems	Using Unsupervised Learning to Harmonize Data Across Data Systems	Methods, Data, & Tools	07/28/2021	Using Unsupervised Learning to Harmonize Data Across Data Systems Methods, Data, & Tools 07/28/2021
https://sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-women	Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table	Publications and Presentations	08/23/2021	Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/comparing-outcomes-trial-eligible-vs-real-world-covid-19	Comparing Outcomes in Trial-Eligible vs Real-World COVID-19 Patients: The Case of Invasive Mechanical Ventilation	Publications and Presentations	08/23/2021	Comparing Outcomes in Trial-Eligible vs Real-World COVID-19 Patients: The Case of Invasive Mechanical Ventilation Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/outpatient-identified-covid-19-and-subsequent-hospitalized	Outpatient-Identified COVID-19 and Subsequent Hospitalized Thrombotic Events	Publications and Presentations	08/23/2021	Outpatient-Identified COVID-19 and Subsequent Hospitalized Thrombotic Events Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/monitoring-medication-use-during-covid-19-pandemic-sentinel	Monitoring Medication Use During the COVID-19 Pandemic in the Sentinel System: The Case of Anticoagulation for Thrombosis	Publications and Presentations	09/15/2021	Monitoring Medication Use During the COVID-19 Pandemic in the Sentinel System: The Case of Anticoagulation for Thrombosis Publications and Presentations 09/15/2021
https://sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs	Methods, Data, & Tools	09/24/2021	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
https://sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-0	Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network	Publications and Presentations	10/14/2021	Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network Publications and Presentations 10/14/2021
https://sentinelinitiative.org/methods-data-tools/methods/development-and-illustration-framework-conducting-nonrandomized-studies	Development and Illustration of a Framework for Conducting Nonrandomized Studies of Medication Safety and Effectiveness Using Healthcare Databases	Methods, Data, & Tools	12/10/2021	Development and Illustration of a Framework for Conducting Nonrandomized Studies of Medication Safety and Effectiveness Using Healthcare Databases Methods, Data, & Tools 12/10/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma	N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis	Analyses	02/18/2022	N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis Analyses 02/18/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/tofacitinib-disease-modifying-anti-rheumatic-drugs-dmards	Tofacitinib, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and Tumor Necrosis Factor Inhibitors (TNFi) Use: A Descriptive Analysis	Analyses	02/24/2022	Tofacitinib, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and Tumor Necrosis Factor Inhibitors (TNFi) Use: A Descriptive Analysis Analyses 02/24/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n	Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis	Analyses	03/01/2022	Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis Analyses 03/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/mometasone-furoate-sinus-implant-use-patients-nasal-polyps	Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis	Analyses	03/03/2022	Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis Analyses 03/03/2022
https://sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel	Augmenting Date of Death & Cause of Death Ascertainment in Sentinel	Methods, Data, & Tools	03/16/2022	Augmenting Date of Death & Cause of Death Ascertainment in Sentinel Methods, Data, & Tools 03/16/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-25-years-old-or	Counts and Characteristics of Individuals 25 Years Old or Younger With Drug-Device or Biologic-Device Combination Use: A Descriptive Analysis	Analyses	04/18/2022	Counts and Characteristics of Individuals 25 Years Old or Younger With Drug-Device or Biologic-Device Combination Use: A Descriptive Analysis Analyses 04/18/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table	Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis	Analyses	06/30/2022	Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Analyses 06/30/2022
https://sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin	Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark	Publications and Presentations	08/26/2022	Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark Publications and Presentations 08/26/2022
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-infants-sentinel-distributed-database-mother	Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table	Publications and Presentations	08/28/2022	Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations 08/28/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-women-descriptive	Utilization of Ibrexafungerp in Pregnant Women: A Descriptive Analysis in TriNetX	Analyses	10/31/2022	Utilization of Ibrexafungerp in Pregnant Women: A Descriptive Analysis in TriNetX Analyses 10/31/2022
https://sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr	Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment	Methods, Data, & Tools	12/09/2022	Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment Methods, Data, & Tools 12/09/2022
https://sentinelinitiative.org/methods-data-tools/methods/development-and-evaluation-electronic-health-record-ehr-information	Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2)	Methods, Data, & Tools	01/27/2023	Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2) Methods, Data, & Tools 01/27/2023
https://sentinelinitiative.org/news-events/publications-presentations/valsartan-losartan-and-irbesartan-use-usa-uk-canada-and	Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study	Publications and Presentations	04/17/2023	Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study Publications and Presentations 04/17/2023
https://sentinelinitiative.org/methods-data-tools/methods/subset-calibration-methods	Subset Calibration Methods	Methods, Data, & Tools	05/08/2023	Subset Calibration Methods Methods, Data, & Tools 05/08/2023
https://sentinelinitiative.org/methods-data-tools/methods/utilization-single-and-multiple-inhaler-triple-therapy-among-patients	Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database	Methods, Data, & Tools	07/31/2023	Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database Methods, Data, & Tools 07/31/2023
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-public-workshop-optimizing-use-postapproval-pregnancy	2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies	Sentinel Initiative Events	09/18/2023	2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies Sentinel Initiative Events 09/18/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-women-descriptive-0	Utilization of Ibrexafungerp in Pregnant Women: A Descriptive Analysis	Analyses	10/02/2023	Utilization of Ibrexafungerp in Pregnant Women: A Descriptive Analysis Analyses 10/02/2023
https://sentinelinitiative.org/studies/drugs/aimovig-erenumab-0	Aimovig (Erenumab) & Signal Identification	Studies	10/12/2023	Aimovig (Erenumab) & Signal Identification Studies 10/12/2023
https://sentinelinitiative.org/methods-data-tools/methods/monitoring-safety-and-effectiveness-covid-19-therapeutics-aim-1-protocol	Monitoring of Safety and Effectiveness of COVID-19 Therapeutics: Aim 1 Protocol Development	Study Protocols & Surveillance Plan	11/17/2023	Monitoring of Safety and Effectiveness of COVID-19 Therapeutics: Aim 1 Protocol Development Study Protocols & Surveillance Plan 11/17/2023
https://sentinelinitiative.org/methods-data-tools/methods/empirical-application-sentinel-electronic-health-record-ehr-and-claims	Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests	Methods, Data, & Tools	11/17/2023	Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests Methods, Data, & Tools 11/17/2023
https://sentinelinitiative.org/methods-data-tools/methods/development-and-refinement-toolkit-large-scale-covariate-adjustment	Development and Refinement of a Toolkit for Large Scale Covariate Adjustment in the Electronic Health Record and Claims Data Partner Network	Methods, Data, & Tools	12/15/2023	Development and Refinement of a Toolkit for Large Scale Covariate Adjustment in the Electronic Health Record and Claims Data Partner Network Methods, Data, & Tools 12/15/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-drug-device-or-biologic-device-combinations	Utilization of Drug-Device or Biologic-Device Combinations: A Descriptive Analysis	Analyses	12/28/2023	Utilization of Drug-Device or Biologic-Device Combinations: A Descriptive Analysis Analyses 12/28/2023
https://sentinelinitiative.org/methods-data-tools/methods/incorporate-range-frequently-used-engineering-features-ehrs-sentinel	Incorporate a Range of Frequently Used Engineering Features from EHRs into the Sentinel Common Data Model in the Sentinel EHR and Claims Linked Data Partner Network	Methods, Data, & Tools	02/09/2024	Incorporate a Range of Frequently Used Engineering Features from EHRs into the Sentinel Common Data Model in the Sentinel EHR and Claims Linked Data Partner Network Methods, Data, & Tools 02/09/2024
https://sentinelinitiative.org/methods-data-tools/methods/empirical-application-sentinel-ehr-and-claims-data-partner-network	Empirical Application of the Sentinel EHR and Claims Data Partner Network to Enhance ARIA Sufficient Inferential Requests and Atypical Descriptive Requests (Use Case Package 2)	Methods, Data, & Tools	02/13/2024	Empirical Application of the Sentinel EHR and Claims Data Partner Network to Enhance ARIA Sufficient Inferential Requests and Atypical Descriptive Requests (Use Case Package 2) Methods, Data, & Tools 02/13/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-gimoti-metoclopramide-nasal-spray-0	Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis	Analyses	03/08/2024	Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis Analyses 03/08/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-women-updated-descriptive	Utilization of Ibrexafungerp in Pregnant Women: An Updated Descriptive Analysis in TriNetX	Analyses	05/17/2024	Utilization of Ibrexafungerp in Pregnant Women: An Updated Descriptive Analysis in TriNetX Analyses 05/17/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-women-updated-0	Utilization of Ibrexafungerp in Pregnant Women: An Updated Descriptive Analysis	Analyses	07/17/2024	Utilization of Ibrexafungerp in Pregnant Women: An Updated Descriptive Analysis Analyses 07/17/2024